#pharmaceutical-industry
#pharmaceutical-industry

London startup

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Eli Lilly's stock surged 635% from late 2020 to summer 2024, driven by innovation and regulatory success.

3 days ago

NYC startup

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (May 2025)

Pfizer has seen a significant decline in stock value despite some strong earnings and forecasts.

London startup

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Eli Lilly's stock surged 635% from late 2020 to summer 2024, driven by innovation and regulatory success.

3 days ago

NYC startup

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (May 2025)

Pfizer has seen a significant decline in stock value despite some strong earnings and forecasts.

more#stock-performance

#trump-administration

4 days ago

Tech industry

Trump hints at tariff reprieve for pharma companies that bring operations back to US

Trump offers pharmaceutical companies a timeline to avoid impending tariffs by repatriating manufacturing to the US.

fromMedCity News

US politics

Trump's Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies - MedCity News

Trump's executive order may change Medicare drug price negotiations, favoring pharmaceutical companies by extending negotiation eligibility for small molecule drugs.

fromwww.nytimes.com

US Elections

Drug Companies Face Hostility as They Hope for Allies Among Trump's Health Picks

Drug executives are concerned about Trump's health policy nominees that could threaten industry regulations, contrasting with expectations for a friendlier administration.

4 days ago

Tech industry

Trump hints at tariff reprieve for pharma companies that bring operations back to US

Trump offers pharmaceutical companies a timeline to avoid impending tariffs by repatriating manufacturing to the US.

fromMedCity News

US politics

Trump's Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies - MedCity News

Trump's executive order may change Medicare drug price negotiations, favoring pharmaceutical companies by extending negotiation eligibility for small molecule drugs.

fromwww.nytimes.com

more#trump-administration

US Elections

Drug Companies Face Hostility as They Hope for Allies Among Trump's Health Picks

Drug executives are concerned about Trump's health policy nominees that could threaten industry regulations, contrasting with expectations for a friendlier administration.

#regulatory-compliance

1 year ago

Avoid These 8 Mistakes When Using AI in Healthcare | HackerNoon

AI in pharma can expedite regulatory processes but requires rigorous validation to avoid costly errors.

Human reviews alone may not suffice to ensure AI accuracy for complex tasks.

1 week ago

OMG science

Selvaraja Elumalai's Digital Evolution at a Leading Pharmaceutical Company | HackerNoon

Selvaraja Elumalai led a transformative automation project, improving laboratory efficiency and regulatory compliance within a major pharmaceutical company.

1 year ago

Avoid These 8 Mistakes When Using AI in Healthcare | HackerNoon

AI in pharma can expedite regulatory processes but requires rigorous validation to avoid costly errors.

Human reviews alone may not suffice to ensure AI accuracy for complex tasks.

more#regulatory-compliance

1 week ago

OMG science

Selvaraja Elumalai's Digital Evolution at a Leading Pharmaceutical Company | HackerNoon

Selvaraja Elumalai led a transformative automation project, improving laboratory efficiency and regulatory compliance within a major pharmaceutical company.

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.

Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Ozempic's explosive sales growth reflects its successful transition from a diabetes treatment to a leading weight loss drug.

Left-wing politics

Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony

Novo Nordisk's weight loss drugs are effective but criticized for their high costs and accessibility issues in the U.S.

Wearables

fromtime.com

3 weeks ago

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.

Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Ozempic's explosive sales growth reflects its successful transition from a diabetes treatment to a leading weight loss drug.

Left-wing politics

Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony

Novo Nordisk's weight loss drugs are effective but criticized for their high costs and accessibility issues in the U.S.

more#obesity-treatment

#healthcare

fromTruthout

US politics

Trump Signs Executive Order Delaying Negotiations for Prescription Drug Prices

Trump's executive order delays Medicare drug price negotiations, benefiting pharmaceutical companies.

fromVulture

Humor

Common Side Effects Took a Different Kind of Mushroom Trip

The series 'Common Side Effects' critiques the healthcare system and highlights moral corruption surrounding a miraculous healing mushroom.

fromTruthout

Trump Signs Executive Order Delaying Negotiations for Prescription Drug Prices

Trump's executive order delays Medicare drug price negotiations, benefiting pharmaceutical companies.

fromVulture

Humor

Common Side Effects Took a Different Kind of Mushroom Trip

The series 'Common Side Effects' critiques the healthcare system and highlights moral corruption surrounding a miraculous healing mushroom.

more#healthcare

#us-tariffs

4 weeks ago

UK politics

Starmer announces support for car and pharma industries in age of insecurity'

Starmer introduces measures to support UK's car and pharmaceutical industries amid US tariff challenges.

Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.

Europe news

Countdown to Trump's tariffs: 'Very grave threat' already slowing down investment, says Taoiseach

Taoiseach Micheál Martin emphasized the importance of protecting Ireland's key industries amidst looming US tariffs.

4 weeks ago

UK politics

Starmer announces support for car and pharma industries in age of insecurity'

Starmer introduces measures to support UK's car and pharmaceutical industries amid US tariff challenges.

Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.

Europe news

Countdown to Trump's tariffs: 'Very grave threat' already slowing down investment, says Taoiseach

Taoiseach Micheál Martin emphasized the importance of protecting Ireland's key industries amidst looming US tariffs.

more#us-tariffs

#ireland

Trump accuses Ireland of stealing US companies in meeting with taoiseach

Trump accused Ireland of stealing the U.S. pharmaceutical industry and its corresponding tax revenue.

Europe news

Taoiseach highlights food, drink and pharma industry as Trump's tariffs loom large over Europe

US tariffs on imports may severely affect Ireland's economy and exports, especially in the pharmaceutical sector.

Trump accuses Ireland of stealing US companies in meeting with taoiseach

Trump accused Ireland of stealing the U.S. pharmaceutical industry and its corresponding tax revenue.

Europe news

Taoiseach highlights food, drink and pharma industry as Trump's tariffs loom large over Europe

US tariffs on imports may severely affect Ireland's economy and exports, especially in the pharmaceutical sector.

Medicine

Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market

Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.

fromArs Technica

Medicine

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

NYC startup

Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)

Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.

6 months ago

Medicine

Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market

Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.

fromArs Technica

Medicine

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

NYC startup

Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)

Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.

more#weight-loss-drugs

#us-ireland-relations

'We don't want to do anything to hurt Ireland' - Trump says US pharmaceutical industry has gone to Ireland as Micheal Martin meets US president in the Oval Office

Trump criticized Ireland for attracting US pharmaceutical companies through advantageous tax policies.

He claims previous US administrations allowed economic segments to be lost to foreign countries.

US politics

'We don't want to do anything to hurt Ireland,' says Trump as Micheal Martin meets US president in the Oval Office

Trump blames Ireland's tax measures for attracting US pharmaceutical companies, creating a trade deficit.

'We don't want to do anything to hurt Ireland' - Trump says US pharmaceutical industry has gone to Ireland as Micheal Martin meets US president in the Oval Office

Trump criticized Ireland for attracting US pharmaceutical companies through advantageous tax policies.

He claims previous US administrations allowed economic segments to be lost to foreign countries.

more#us-ireland-relations

'We don't want to do anything to hurt Ireland,' says Trump as Micheal Martin meets US president in the Oval Office

Trump blames Ireland's tax measures for attracting US pharmaceutical companies, creating a trade deficit.

'We don't want to do anything to hurt Ireland' - says Trump as Micheal Martin meets US president in the Oval Office

Trump claims Ireland benefits from US pharmaceutical companies due to favorable tax policies.

He criticizes the EU for unfair practices against US companies.

#eli-lilly

fromwww.aljazeera.com

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.

Business

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Pharmaceutical stocks are relatively stable during economic downturns, appealing to long-term investors despite drug pricing concerns.

fromwww.aljazeera.com

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.

Business

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Pharmaceutical stocks are relatively stable during economic downturns, appealing to long-term investors despite drug pricing concerns.

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary

Trump's appointment of Robert F. Kennedy Jr. as HHS secretary raises concerns among health professionals and investors due to his vaccine skepticism.

fromAxios

Miscellaneous

RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation

Ramaswamy and Kennedy's differing views on drug regulation add uncertainty for pharmaceutical companies under the new administration.

fromtime.com

Health

RFK Jr. Outlines His Health Secretary Priorities in Post-Confirmation Interview With Fox News

Robert F. Kennedy Jr. emphasizes the need for a holistic approach to health, addressing both physical and spiritual crises in the U.S.

Coronavirus

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary

Trump's appointment of Robert F. Kennedy Jr. as HHS secretary raises concerns among health professionals and investors due to his vaccine skepticism.

fromAxios

Miscellaneous

RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation

Ramaswamy and Kennedy's differing views on drug regulation add uncertainty for pharmaceutical companies under the new administration.

fromtime.com

Health

RFK Jr. Outlines His Health Secretary Priorities in Post-Confirmation Interview With Fox News

Robert F. Kennedy Jr. emphasizes the need for a holistic approach to health, addressing both physical and spiritual crises in the U.S.

more#health-policy

#astrazeneca

Miscellaneous

AstraZeneca says it takes China investigation very seriously'

AstraZeneca is cooperating with Chinese authorities amidst investigations into alleged illegal importation of cancer drugs.

Miscellaneous

AstraZeneca, Whitehall, and a failed 450m deal for the next generation in vaccines. What went wrong?

AstraZeneca canceled its 450m vaccine factory expansion, revealing issues with government negotiations and corporate investment in the UK.

Business

AstraZeneca says it's taking China's investigations into fraud, illegal drug importation and data collection 'very seriously'

AstraZeneca is cooperating with Chinese investigations into potential illegal activities, emphasizing its commitment to the Chinese market and innovative medicines.

Miscellaneous

AstraZeneca says it takes China investigation very seriously'

AstraZeneca is cooperating with Chinese authorities amidst investigations into alleged illegal importation of cancer drugs.

Miscellaneous

AstraZeneca, Whitehall, and a failed 450m deal for the next generation in vaccines. What went wrong?

AstraZeneca canceled its 450m vaccine factory expansion, revealing issues with government negotiations and corporate investment in the UK.

Business

AstraZeneca says it's taking China's investigations into fraud, illegal drug importation and data collection 'very seriously'

AstraZeneca is cooperating with Chinese investigations into potential illegal activities, emphasizing its commitment to the Chinese market and innovative medicines.

The Dubious Return of the Brutalists

ACT UP's occupation of Burroughs Wellcome highlighted the fight against unaffordable HIV treatment and the power of grassroots activism.

fromwww.nytimes.com

Digital life

Review: In Common Side Effects,' It's Fungus vs. Them

'Common Side Effects' presents a humorous critique of the pharmaceutical industry through the eyes of an eccentric scientist and a magical mushroom.

#inflation-reduction-act

Miscellaneous

fromCbsnews

fromIPWatchdog.com | Patents & Intellectual Property Law

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

Medicare has initiated price negotiations for 15 drugs to reduce costs for seniors, emphasizing the importance of affordable medication.

Privacy professionals

Pharma Companies' Challenge to Inflation Reduction Act Heats Up

The IRA aims to lower drug prices but faces constitutional challenges from pharmaceutical companies over pricing and First and Fifth Amendment rights.

Miscellaneous

fromCbsnews

fromIPWatchdog.com | Patents & Intellectual Property Law

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

Medicare has initiated price negotiations for 15 drugs to reduce costs for seniors, emphasizing the importance of affordable medication.

more#inflation-reduction-act

Privacy professionals

Pharma Companies' Challenge to Inflation Reduction Act Heats Up

The IRA aims to lower drug prices but faces constitutional challenges from pharmaceutical companies over pricing and First and Fifth Amendment rights.

fromwww.dw.com

Medicine

Novel antibiotics: Regional research is (half) the solution DW 01/15/2025

Antibiotic resistance is escalating, necessitating urgent local drug development, particularly in low- and middle-income countries.

Medicine

fromBusiness Matters

PACE - the supply chain of the future

PACE from Sewtec Automation aims to transform pharmaceutical production by drastically reducing lead times and increasing efficiency through innovative automation.

#drug-discovery

fromwww.bbc.com

Artificial intelligence

How AI uncovers new ways to tackle difficult diseases

AI is revolutionizing drug discovery, potentially reducing time and cost while increasing success rates for new treatments.

fromComputerWeekly.com

Artificial intelligence

Medtech startup brings Oracle AI to bear on cancer drug research | Computer Weekly

AI-driven drug discovery is poised to revolutionize cancer treatment, promising new opportunities for oncologists to improve patient care.

fromwww.bbc.com

How AI uncovers new ways to tackle difficult diseases

AI is revolutionizing drug discovery, potentially reducing time and cost while increasing success rates for new treatments.

fromComputerWeekly.com

Medtech startup brings Oracle AI to bear on cancer drug research | Computer Weekly

AI-driven drug discovery is poised to revolutionize cancer treatment, promising new opportunities for oncologists to improve patient care.

Mark Cuban Says He Isn't 'Trying to Go to Mars' | Entrepreneur

Mark Cuban's Cost Plus Drugs aims to disrupt the pharmaceutical industry by significantly lowering medication prices while being a public benefit corporation.

fromWIRED

Miscellaneous

Mark Cuban's War on Drug Prices: 'How Much Fucking Money Do I Need?'

Mark Cuban believes transparency in drug pricing through Cost Plus Drugs effectively disrupts the pharmaceutical industry and reduces costs for consumers.

Business

fromEntrepreneur

4 months ago

Mark Cuban Says He Isn't 'Trying to Go to Mars' | Entrepreneur

Mark Cuban's Cost Plus Drugs aims to disrupt the pharmaceutical industry by significantly lowering medication prices while being a public benefit corporation.

fromWIRED

Miscellaneous

Mark Cuban's War on Drug Prices: 'How Much Fucking Money Do I Need?'

Mark Cuban believes transparency in drug pricing through Cost Plus Drugs effectively disrupts the pharmaceutical industry and reduces costs for consumers.

The Chilling' Fatal Shooting of a C.E.O. Has Business Leaders on Edge

The increase in violence towards executives, particularly in the healthcare sector, is a growing concern for business leaders.

fromFortune

6 months ago

Artificial intelligence

How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute

Dave Williams dedicates 20% of his time to cybersecurity at Merck, underlining its critical importance amid escalating cyber threats.

fromFortune

6 months ago

Miscellaneous

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

Activist investor Starboard Value's proxy fight against Pfizer has intensified, with claims of CEO Bourla's underperformance amid shifting loyalties from former Pfizer executives.

#stock-market

Public health

Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans

Moderna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.

The company faces challenges following its pandemic success, prompting a strategic shift in investment.

Business

3 Top Pharma Stocks to Buy in October 2024

The pharmaceutical industry is critical for health and is projected to grow significantly.

Investors should consider companies with sustainable pipelines for long-term gains.

Eli Lilly's impressive stock growth demonstrates the industry's potential for returns.

Public health

Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans

Moderna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.

The company faces challenges following its pandemic success, prompting a strategic shift in investment.

Business

3 Top Pharma Stocks to Buy in October 2024

The pharmaceutical industry is critical for health and is projected to grow significantly.

Investors should consider companies with sustainable pipelines for long-term gains.

Eli Lilly's impressive stock growth demonstrates the industry's potential for returns.

more#stock-market

fromNature

Medicine

The pharmaceutical industry must embrace synthetic alternatives to horseshoe-crab blood

The US Pharmacopeia's adoption of chapter 86 enables pharmaceutical companies to transition to synthetic endotoxin testing methods.

fromeLearning Industry